Available Technologies

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Find technologies available for licensing from all ten University of California (UC) campuses.

Multiple-Bits-Per-Cell Voltage-Controlled Magnetic Memory

UCLA researchers in the Department of Electrical and Computer Engineering have developed a new random access memory read/write method that achieves new levels of speed, scalability, and memory density.

Micro- and Nanocomposite Support Structures for Reverse Osmosis Thin Film Membranes

UCLA researchers in the Department of Civil and Environmental Engineering have invented a novel nanofiltration (NF) and reverse osmosis (RO) composite membrane for water desalination applications.

Immunoassay For Human Erythroferrone

UCLA researchers from the Department of Medicine have developed a novel immunoassay for human erythroferrone.

Infrared Detectors And Heat Recycling Cells Based On Metallo-Graphene Nanocomposites

UCLA researchers in the Department of Electrical Engineering have developed a high-responsivity photodetector that utilizes metallo-graphene nanocomposites for superior detection of infrared wavelengths.

A Device, Methodology And System For Monitoring, Classifying And Encouraging Activity

UCLA researchers in the Department of Computer Science have developed a new technology to fight the growing obesity epidemic by encouraging exercise.

Targeting Lentiviral Vectors To Specific Cells And Tissues

Researchers in the UCLA Departments of Medicine and Microbiology, Immunology and Molecular Genetics have developed retroviral vectors pseudotyped with a modified Sinbus virus envelope that exhibit reduced tropism and can be used for the targeted transduction of heterologous genes into cells.

A Polynomial Particle-In-Cell Method

Researchers at UCLA led by Joseph Teran have developed a new technique that can better simulate the motion of particles in fluid.

Modulating IRE1a/ß Kinase for Treatment of Unfolded Protein Response (UPR)-related Diseases

This invention identifies a series of compounds which can selectively regulate the kinase activity of IRE1α and IRE1β, which are paralogous enzymes critical for the activation of the unfolded protein response (UPR) and that may have implications in cell-degenerative diseases such as diabetes, cancer, fibrosis, asthma, and retinitis pigmentosa.